Patents by Inventor Ofir Ramot

Ofir Ramot has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10576116
    Abstract: The present invention relates to extracts derived from plants and/or fractions thereof, compositions comprising same and use thereof in protecting tissues from damages caused by exogenous toxins. In particular, the present invention relates to polar extract and/or fraction thereof derived from Asteriscus graveolens, compositions comprising same and use thereof in protecting tissues comprising epithelial cell from the deleterious effect of exogenous toxins, particularly toxins originating from environmental pollution.
    Type: Grant
    Filed: February 1, 2016
    Date of Patent: March 3, 2020
    Assignee: I.B.R. Israeli Biotechnology Research Ltd.
    Inventors: Ofir Ramot, Fabien Havas, Eyal Kalo, Liki Von Oppen-Bezalel, Raffi Arnon, Olga Ben-Chitrit, Inon Perry
  • Publication number: 20180021394
    Abstract: The present invention relates to extracts derived from plants and/or fractions thereof, compositions comprising same and use thereof in protecting tissues from damages caused by exogenous toxins. In particular, the present invention relates to polar extract and/or fraction thereof derived from Asteriscus graveolens, compositions comprising same and use thereof in protecting tissues comprising epithelial cell from the deleterious effect of exogenous toxins, particularly toxins originating from environmental pollution.
    Type: Application
    Filed: February 1, 2016
    Publication date: January 25, 2018
    Inventors: Ofir Ramot, Fabien Havas, Eyal Kalo, Liki Von Oppen-Bezalel, Raffi Arnon, Olga Ben-Chitrit, Inon Perry
  • Publication number: 20030104084
    Abstract: A process for obtaining a solid soy isoflavone- and protein-containing isolate in which isoflavones constitute at least 7% of the isolate and are present in predominantly glycoside form, (genistin+genistein) constitute at least 50% of the isoflavones, the weight ratio (genistin+genistein):(daidzin+daidzein) is at least 1.5:1 and the bulk density is at least 0.57 g/ml. The process includes the sequential steps of (a) heating a soy soluble extract (SSE), made by aqueous alcohol extraction of defatted soy solids and evaporation of the alcohol, at acid pH and at a temperature within the range 70°-90° C. to cause sedimentation of an insoluble fraction containing saponin, trypsin inhibitor and isoflavone compounds; (b) cooling the mixture from step (a) to a temperature of not lower than 30° C. and separating the insoluble fraction from supernatant liquid in the mixture of step (a) at a temperature of not lower than 30° C.
    Type: Application
    Filed: September 16, 2002
    Publication date: June 5, 2003
    Inventors: Ofir Ramot, Trevor Meredith